Tag archives for Edronax
Reboxetine Mesilate
Posted By Kelly On Wednesday, December 22nd 2010 under: Antidepressants Tags: Edronax, magrilan
Drug Nomenclature
Synonyms: FCE-20124 (reboxetine or reboxetine mesilate); PNU-155950E; Reboxetina, mesilato de; Reboxetine Mesylate
BAN: Reboxetine Mesilate
USAN: Reboxetine Mesylate
INN: Reboxetine Mesilate
INN: Mesilato de reboxetina
INN: Réboxétine, Mésilate de
INN: Reboxetini Mesilas
INN: Ребоксетина Мезилат
Chemical name: (±)-(2RS)-2-morpholine methanesulphonate
Molecular formula: C19H23NO3,CH4O3S =409.5
CAS: 71620-89-8; 98769-81-4 (both reboxetine); 98769-82-5; 98769-84-7 (both reboxetine mesilate)
ATC code: N06AX18
Adverse Effects
Adverse effects most commonly seen with reboxetine include insomnia, dry mouth, constipation, and increased ... Read More
Antidepressant Gets High Marks
Posted By Kelly On Sunday, May 2nd 2010 under: Research Digest Tags: Edronax, Prozac
Results from several clinical studies designed to assess the effectiveness and tolerability of Reboxetine (Edronax), a new antidepressant agent, were announced recently at the annual meeting of the American Psychiatric Association.
Reboxetine, produced by Pharmacia & Upjohn, is the first of a new class of antidepressant medications known as selective norepinephrine reuptake inhibitors. It works through a novel mechanism of action, affecting the norepinephrine system of the body. Researchers have long ... Read More
